210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Material disclosure
CEO Appointment - Zachary Roberts Named President and CEO of Allogene Therape...
Reports First Quarter 2026 Financial Results and Business Update
Annual Report to Security Holders
Announces Pricing of Public Offering of Common Stock
Other Events
Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership